Skip to main content
Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
17.76
+0.16 (0.91%)
At close: May 13, 2025, 4:00 PM
17.76
0.00 (0.00%)
After-hours: May 13, 2025, 4:00 PM EDT

Oculis Holding AG Revenue

Oculis Holding AG had revenue of 285.00K CHF in the quarter ending March 31, 2025, with 28.38% growth. This brings the company's revenue in the last twelve months to 749.00K, down -14.50% year-over-year. In the year 2024, Oculis Holding AG had annual revenue of 686.00K, down -22.31%.

Revenue (ttm)
749.00K CHF
Revenue Growth
-14.50%
P/S Ratio
1,109.69
Revenue / Employee
15,286 CHF
Employees
49
Market Cap
940.28M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024686.00K-197.00K-22.31%
Dec 31, 2023883.00K-29.00K-3.18%
Dec 31, 2022912.00K-48.00K-5.00%
Dec 31, 2021960.00K-33.00K-3.32%
Dec 31, 2020993.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

OCS News

More News